213 related articles for article (PubMed ID: 26232746)
1. Effects of fertility drugs on cancers other than breast and gynecologic malignancies.
Brinton LA; Moghissi KS; Scoccia B; Lamb EJ; Trabert B; Niwa S; Ruggieri D; Westhoff CL
Fertil Steril; 2015 Oct; 104(4):980-988. PubMed ID: 26232746
[TBL] [Abstract][Full Text] [Related]
2. Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort.
Trabert B; Lamb EJ; Scoccia B; Moghissi KS; Westhoff CL; Niwa S; Brinton LA
Fertil Steril; 2013 Dec; 100(6):1660-6. PubMed ID: 24011610
[TBL] [Abstract][Full Text] [Related]
3. Ovarian cancer risk after the use of ovulation-stimulating drugs.
Brinton LA; Lamb EJ; Moghissi KS; Scoccia B; Althuis MD; Mabie JE; Westhoff CL
Obstet Gynecol; 2004 Jun; 103(6):1194-203. PubMed ID: 15172852
[TBL] [Abstract][Full Text] [Related]
4. Fertility drugs and incidence of thyroid cancer in a Danish nationwide cohort of 146 024 infertile women.
Lindquist S; Kjær SK; Albieri V; Frederiksen K; Hansen T; Nøhr B; Jensen A
Hum Reprod; 2022 Apr; 37(4):838-847. PubMed ID: 35020884
[TBL] [Abstract][Full Text] [Related]
5. Long-term relationship of ovulation-stimulating drugs to breast cancer risk.
Brinton LA; Scoccia B; Moghissi KS; Westhoff CL; Niwa S; Ruggieri D; Trabert B; Lamb EJ
Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):584-93. PubMed ID: 24700523
[TBL] [Abstract][Full Text] [Related]
6. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs.
Althuis MD; Scoccia B; Lamb EJ; Moghissi KS; Westhoff CL; Mabie JE; Brinton LA
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):668-74. PubMed ID: 16150258
[TBL] [Abstract][Full Text] [Related]
7. Risk of colorectal cancer after use of fertility drugs-results from a large Danish population-based cohort of women with infertility.
Møller M; Kjær SK; Lindquist S; Brown Frandsen CL; Albieri V; Viuff JH; Nøhr B; Olsen A; Jensen A
Fertil Steril; 2022 Oct; 118(4):738-747. PubMed ID: 36041966
[TBL] [Abstract][Full Text] [Related]
8. Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort.
Brinton LA; Westhoff CL; Scoccia B; Lamb EJ; Trabert B; Niwa S; Moghissi KS
Hum Reprod; 2013 Oct; 28(10):2813-21. PubMed ID: 23943795
[TBL] [Abstract][Full Text] [Related]
9. Cancer Risk in Women Treated with Fertility Drugs According to Parity Status-A Registry-based Cohort Study.
Reigstad MM; Storeng R; Myklebust TÅ; Oldereid NB; Omland AK; Robsahm TE; Brinton LA; Vangen S; Furu K; Larsen IK
Cancer Epidemiol Biomarkers Prev; 2017 Jun; 26(6):953-962. PubMed ID: 28108444
[No Abstract] [Full Text] [Related]
10. Fertility Drugs Associated with Thyroid Cancer Risk: A Systematic Review and Meta-Analysis.
Yu Q; Lv X; Liu K; Ma D; Wu Y; Dai W; Jiang H
Biomed Res Int; 2018; 2018():7191704. PubMed ID: 29862285
[TBL] [Abstract][Full Text] [Related]
11. In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services.
Brinton LA; Trabert B; Shalev V; Lunenfeld E; Sella T; Chodick G
Fertil Steril; 2013 Apr; 99(5):1189-96. PubMed ID: 23375197
[TBL] [Abstract][Full Text] [Related]
12. Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.
Bjørnholt SM; Kjaer SK; Nielsen TS; Jensen A
Hum Reprod; 2015 Jan; 30(1):222-31. PubMed ID: 25376453
[TBL] [Abstract][Full Text] [Related]
13. Risk of breast cancer in women treated with ovarian stimulation drugs for infertility: a systematic review and meta-analysis.
Beebeejaun Y; Athithan A; Copeland TP; Kamath MS; Sarris I; Sunkara SK
Fertil Steril; 2021 Jul; 116(1):198-207. PubMed ID: 34148584
[TBL] [Abstract][Full Text] [Related]
14. Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study.
Potashnik G; Lerner-Geva L; Genkin L; Chetrit A; Lunenfeld E; Porath A
Fertil Steril; 1999 May; 71(5):853-9. PubMed ID: 10231045
[TBL] [Abstract][Full Text] [Related]
15. Infertility, ovulation induction treatments and the incidence of breast cancer--a historical prospective cohort of Israeli women.
Lerner-Geva L; Keinan-Boker L; Blumstein T; Boyko V; Olmar L; Mashiach S; Rabinovici J; Potashnik G; Lunenfeld E; Schenker JG; Shushan A; Fishman A; Cohen I; Vagman I; Lunenfeld B
Breast Cancer Res Treat; 2006 Nov; 100(2):201-12. PubMed ID: 16685587
[TBL] [Abstract][Full Text] [Related]
16. Thyroid cancer risk in women with infertility and association with fertility medications in Taiwan.
Ding DC; Chen W; Wang JH; Lin SZ; Sung FC
Cancer; 2019 May; 125(10):1701-1708. PubMed ID: 30645760
[TBL] [Abstract][Full Text] [Related]
17. Cancer incidence in a cohort of infertile women.
Modan B; Ron E; Lerner-Geva L; Blumstein T; Menczer J; Rabinovici J; Oelsner G; Freedman L; Mashiach S; Lunenfeld B
Am J Epidemiol; 1998 Jun; 147(11):1038-42. PubMed ID: 9620047
[TBL] [Abstract][Full Text] [Related]
18. Ovulation inducing agents and cancer risk: review of literature.
Impicciatore GG; Tiboni GM
Curr Drug Saf; 2011 Sep; 6(4):250-8. PubMed ID: 22129320
[TBL] [Abstract][Full Text] [Related]
19. Childhood tumor risk after treatment with ovulation-stimulating drugs.
Brinton LA; Krüger Kjaer S; Thomsen BL; Sharif HF; Graubard BI; Olsen JH; Bock JE
Fertil Steril; 2004 Apr; 81(4):1083-91. PubMed ID: 15066468
[TBL] [Abstract][Full Text] [Related]
20. Uterine cancer after use of clomiphene citrate to induce ovulation.
Althuis MD; Moghissi KS; Westhoff CL; Scoccia B; Lamb EJ; Lubin JH; Brinton LA
Am J Epidemiol; 2005 Apr; 161(7):607-15. PubMed ID: 15781949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
